Quick Answer
INTEGRA LIFESCIENCES HOLDINGS CORP reported Stockholders Equity of $1.04 billion for fiscal year 2025.
INTEGRA LIFESCIENCES HOLDINGS CORP Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.04B | -32.5% |
| 2024 | $1.55B | -2.7% |
| 2023 | $1.59B | -12.0% |
| 2022 | $1.80B | +7.1% |
| 2021 | $1.68B | +11.2% |
| 2020 | $1.51B | +6.9% |
| 2019 | $1.42B | +3.0% |
| 2018 | $1.38B | +43.0% |
| 2017 | $962.31M | +14.6% |
| 2016 | $839.67M | +11.7% |
| 2015 | $751.44M | +6.7% |
| 2014 | $704.32M | +5.7% |
| 2013 | $666.09M | +28.6% |
| 2012 | $517.77M | +5.1% |
| 2011 | $492.64M | -1.5% |
| 2010 | $499.96M | +12.4% |
| 2009 | $444.88M | +19.5% |
| 2008 | $372.31M | +29.5% |
| 2007 | $287.59M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.04B | -31.8% | -0.1% |
| June 30, 2025 | $1.04B | -32.3% | -31.9% |
| March 31, 2025 | $1.52B | -4.6% | -1.4% |
| December 31, 2024 | $1.55B | -2.7% | +1.6% |
| September 30, 2024 | $1.52B | -3.6% | -0.8% |
| June 30, 2024 | $1.53B | -8.9% | -4.0% |
| March 31, 2024 | $1.60B | -4.6% | +0.6% |
| December 31, 2023 | $1.59B | -12.0% | +0.5% |
- INTEGRA LIFESCIENCES HOLDINGS CORP showed a decrease of -32.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2007–2025 period, INTEGRA LIFESCIENCES HOLDINGS CORP’s stockholders equity has grown by 262.8% (from $287.59 million to $1.04 billion).
- The most recent figure is from INTEGRA LIFESCIENCES HOLDINGS CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: